ZARONTIN (ETHOSUXIMIDE) IN THE TREATMENT OF PETIT MAL AND RELATED DISORDERS.
D000293:Adolescent; D000927:Anticonvulsants; D035843:Biomedical Research; D002648:Child; D003718:Denmark; D004358:Drug Therapy; D004827:Epilepsy; D004832:Epilepsy, Absence; D004830:Epilepsy, Tonic-Clonic; D005013:Ethosuximide; D006801:Humans; D007223:Infant; D009207:Myoclonus; D010113:Oxyphenbutazone; D010634:Phenobarbital; D010672:Phenytoin; D011760:Pyrrolidinones; D012640:Seizures; D014116:Toxicology
D000927:Anticonvulsants; D011760:Pyrrolidinones; D005013:Ethosuximide; D010672:Phenytoin; D010113:Oxyphenbutazone; D010634:Phenobarbital
ADOLESCENCE; ANTICONVULSANTS; CHILD; CLINICAL RESEARCH; DENMARK; DIPHENYLHYDANTOIN; DRUG THERAPY; EPILEPSY, GRAND MAL; EPILEPSY, PETIT MAL; ETHOSUXIMIDE; INFANT; MYOCLONUS; OXYPHENBUTAZONE; PHENOBARBITAL; PYRROLIDINONES; TOXICOLOGIC REPORT